Smarter development starts earlier than you think! Join Catalent and industry experts for an in-person seminar on March 2, 2026 to explore how smarter early-phase decisions can de-risk development, protect budgets, and build asset value. Together, we'll exchange practical guidance on: • Smarter early-phase development decisions • Improving manufacturability and supply reliability • Expanding oral delivery options for complex molecules • Evaluating CDMO partners with confidence Register now to secure your spot: https://ow.ly/x9Uq50YbQZp #DrugDevelopment #OralDrugDelivery #Biopharma #CDMO
About us
Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.
- Website
-
https://www.catalent.com
External link for Catalent
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Tampa, Florida
- Type
- Public Company
- Specialties
- Analytical Chemistry, Clinical Supply, Biotech, Pharmaceutical Supply Chain, Biologics, Formulation Development, Drug Delivery, Clinical Packaging, Dose Form Manufacturing, Gene Therapy, Vaccine Production, Pharmaceutical, Drug Development, Cell Therapy, Biopharmaceutical, and Innovation
Locations
Employees at Catalent
Updates
-
Catalent is heading to CRBE West Summit, February 24–25 in San Diego and we’re excited to be contributing to advance drug development and delivery of peptides and macromolecules. Join us as Karunakar (Karu) Sukuru, Global VP, Pharma Product Development & Head of Scientific Advisory, presents “Advances in Oral Delivery of Macromolecules” on Wednesday, February 25 (9:40–10:10am PST). The session will explore how modified release technologies, bioavailability enhancement, and scientific innovation can accelerate your product’s path to market. 📍 Attending the summit? Book a meeting with Catalent’s experts to discuss strategies tailored to your development challenges: https://ow.ly/ukzq50YbQMw #CRBEWest #Catalent #DrugDevelopment #Macromolecules #Peptides #OralDelivery
-
Don’t miss your chance to join us tomorrow, February 10 for an Ask the Expert session on accelerating antibody development. In this webinar, we’ll walk through Catalent’s proven 8‑month path from gene to GMP drug substance and the key strategies that make faster, more reliable development possible. Register now to secure your spot: https://ow.ly/Ma2450YbJCw #AntibodyDevelopment #Biologics #DrugDevelopment #GeneToGMP #CDMO #CellLineDevelopment
-
-
This February, Catalent celebrates the impact, leadership and heritage of Black communities. We also honor the important role of REACH, our Employee Resource Group open to all employees and dedicated to advancing the pride and value of employees of African culture and heritage, in promoting inclusion and strengthening our global team. As Executive Sponsor of REACH, Sherief Shaaban, Chief Commercial Officer at Catalent, shares, “Recognizing Black history deepens our employees’ shared understanding of one another, fostering stronger collaboration and enabling the delivery of the highest quality, safety and outcomes for our patients.” At Catalent, these values drive our Patient First mindset and our dedication to customer excellence. By learning from diverse experiences, we champion the missions that matter, helping us better serve the patients and partners who rely on us every day. #BlackHistoryMonth2026 #Inclusion
-
-
Winchester is home to Catalent’s flagship U.S. manufacturing site for large-scale, complex controlled-release oral dose forms - helping innovators bring advanced therapies to market and to patients with confidence. With a proven track record for reliability, scalability and quality, Catalent Winchester offers integrated capabilities to scale oral solid dose programs from development through commercial supply. Take a closer look at our Winchester facility: https://ow.ly/W6b850Y9cwF #OralSolidDose #PharmaManufacturing #CDMO #DrugDevelopment
-
-
Catalent is excited to attend World BI’s Clinical Trial Supply Conference EU in France next week! This event brings leaders from pharma, biotech, and clinical research together to tackle the biggest challenges in clinical trial supply chains - from supply continuity and temperature-controlled logistics to direct-to-patient delivery. Don’t miss our session at 2:40 PM on February 10. Dr. Claire Quinn, PhD will present “Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk,” sharing practical insights to help sponsors anticipate challenges and build more resilient supply strategies. If you’re attending, let’s connect in Nice! Book a meeting with us: https://ow.ly/NIAN50Y9coi #ClinicalTrials #ClinicalSupplyChain #WorldBI #Biotech
-
See you at Advanced Therapies Week 2026! As cell & gene therapies rapidly evolve, the right partner matters. Our team will be onsite at Booth #714 to discuss end‑to‑end support—from early development through commercial‑scale manufacturing—to help bring advanced therapies to patients faster. We’re proud to contribute to the program, beginning with a conversation with Nicole K. Paulk, PhD, CEO & Founder of Siren Biotechnology, on The Hunger Games: Selecting the Right Outsourcing Partner in the New Era of Advanced Therapies, followed by Process Intelligence: Driving Quality & Safety Through Robust In‑Process Analytics, presented by Xuan Guo, Director of Product Development at Catalent. Attending? Schedule a meeting with us: https://ow.ly/8H9z50Y8M1P #AdvancedTherapiesWeek #CellAndGeneTherapy #CGT
-
What if your supplements were as enjoyable as they are effective? Catalent’s soft chew technology supports high active dose loading in a great-tasting, easy-to-use format - ideal for applications like creatine and other performance-driven supplements. Innovation designed to fit seamlessly into active lifestyles! See what’s possible: https://ow.ly/ok7i50Y8G2g #ConsumerHealth #SportsNutrition #Creatine #Nutraceuticals #DietarySupplements #ProductInnovation
-
-
Lifecycle management is about more than extending timelines - it’s about creating better experiences for patients and stronger value for brands. Hear how Zydis® ODT can improve patient experience, optimize bioavailability and unlock new opportunities for mature products - backed by Catalent’s ability to execute with speed, scale and differentiation. #Zydis #DrugDelivery #ODT #LCM
-
Innovation in neuroscience requires collaboration across the entire value chain. Catalent will be at Bio-Neuroscience 2026, February 24-26 in Amsterdam, to showcase how Zydis® ODT technology supports patient-centric CNS drug delivery and helps translate research into meaningful therapies. Join us as we champion the missions that matter most in CNS innovation! Schedule a meeting with us: https://ow.ly/f9Oo50Y60Vt #BioNeuroscience2026 #Neuroscience #DrugDelivery #CNS
-